BioSig Technologies, Inc.
BSGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 122.2% | -93.7% | -35.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 80.1% | 54.9% |
| R&D Expenses | $1 | $5 | $6 | $6 |
| G&A Expenses | $12 | $23 | $21 | $28 |
| SG&A Expenses | $12 | $23 | $21 | $28 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13 | $29 | $27 | $34 |
| Operating Income | -$13 | -$29 | -$27 | -$33 |
| % Margin | -32,155% | -158,400% | -9,533.2% | -7,576.2% |
| Other Income/Exp. Net | $3 | -$0 | $0 | $1 |
| Pre-Tax Income | -$10 | -$29 | -$27 | -$33 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$29 | -$27 | -$31 |
| % Margin | -25,825% | -161,338.9% | -9,535.3% | -7,111.6% |
| EPS | -0.074 | -0.4 | -0.63 | -0.94 |
| % Growth | 81.6% | 36.5% | 33% | – |
| EPS Diluted | -0.074 | -0.4 | -0.63 | -0.94 |
| Weighted Avg Shares Out | 140 | 74 | 43 | 34 |
| Weighted Avg Shares Out Dil | 140 | 74 | 43 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | -$12 | -$28 | -$27 | -$33 |
| % Margin | -31,052.5% | -156,394.4% | -9,430.8% | -7,531.3% |